Sjogren's Syndrome Market, by Drug (Antimalarial Quinolines, Cholinergic Agonists, Corticosteroids and Others ), by type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

Sjogren's syndrome is systematic autoimmune disorder which effect the entire body, along with complication such as, chronic pain, major organ involvement, profound fatigue, neuropathies and Sjogren's syndrome zmphomas.

For the treatment of Sjogren's syndrome different medication such as methotrexate available to manage the syndrome. Currently no single medication has been conclusively proven to treat the progression of Sjogren's.

Antimalarial Quinolines, Cholinergic Agonists and Corticosteroids are the prescription drug used for the treatment of Sjogren's.

Market Dynamics

Increasing prevalence of Sjogren's syndrome is expected to drive the market growth during the forecast period.

For instance, according to the Sjogren's Foundation 2021, around 3 to 4 million people in the U.S. suffer from Sjogren's syndrome which is as common as rheumatoid arthritis (RA), and three times as common as systemic lupus erythematosus (SLE).

Key features of the study:

This report provides an in-depth analysis of the global sjogren's syndrome market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global sjogren's syndrome Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include ADVANZ Pharma, Bristol Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Novartis/MorphoSys, RemeGen, Resolve Therapeutics, Tear Solutions, VIELABIO, Otsuka Pharmaceutical Co., Ltd., and Bridge Pharma Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global sjogren's syndrome Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sjogren's syndrome Market

Detailed Segmentation:

Global Sjogren's Syndrome Market, By Drug:
- Antimalarial Quinolines
- Cholinergic Agonists
- Corticosteroids
- Others (Pain Relief Medication and late phase drug)
Global Sjogren's Syndrome Market, By Type:
- Primary
- Secondary
Global Sjogren's Syndrome Market, By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Sjogren's Syndrome Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest Of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- ADVANZ Pharma *
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Bristol Myers Squibb
- Daiichi Sankyo
- GlaxoSmithKline
- Novartis/MorphoSys
- RemeGen
- Resolve Therapeutics
- TearSolutions
- VIELABIO
- Otsuka Pharmaceutical Co., Ltd.
- Bridge Pharma Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI5210

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug
- Market Snippet, By Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Drivers
Restraints
Opportunities
Impact Analysis
Key Development Strategies
Mergers And Acquisition Scenario
Market Trends
Brand Analysis
Regulatory Scenario
PEST Analysis
Pricing Analysis
Pipeline Analysis

4. Global Sjogren's syndrome Market - Impact of Coronavirus (Covid-19) Pandemic

COVID-19 Epidemiology
Impact on Manufacturing
Impact on Manufacturing

5. Global Sjogren's syndrome Market, By Drug, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
Antimalarial Quinolines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Cholinergic Agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Others (Pain Relief Medication and late phase drug)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Sjogren's syndrome Market, By Type, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
Primary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Secondary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Sjogren's syndrome Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

8. Global Sjogren's syndrome Market, By Region, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
North America
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Region/Country, 2017 - 2030, (US$ Mn)
South Africa
Central Africa
North Africa

9. Competitive Landscape

Competitive Snapshot
- ADVANZ Pharma *
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- Bristol Myers Squibb
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- Daiichi Sankyo
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- GlaxoSmithKline
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- Novartis/MorphoSys
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- RemeGen
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- Resolve Therapeutics
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- TearSolutions
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- VIELABIO
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- Otsuka Pharmaceutical Co., Ltd.
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- Bridge Pharma Inc.
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies

10. Section

References
Research Methodology
About us and Sales Contact

Sjogren's Syndrome Market, by Drug (Antimalarial Quinolines, Cholinergic Agonists, Corticosteroids and Others ), by type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030